CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

What does the new FDA guidance mean for clinical trials in early Alzheimer’s disease?

The latest FDA draft guidance for clinical trials in early Alzheimer’s disease presents many new opportunities and challenges for drug development. 

WEBINAR: Finding the right patients for clinical trials in early Alzheimer's disease

Dr Kenton Zavitz, Director of Clinical Affairs at Cambridge Cognition, and Dr Robert Smith, Consultant Neuropsychologist, hosted a webinar to discuss clinical trials for early Alzheimer’s disease.

Join them to hear more about overcoming the barriers to expedite the drug development process.

Tuesday 22nd May 2018, 11 a.m. EDT

web-based testing, wearables, voice, virtual clinical trials, technology, swm, stigma, social cognition, smartphones, schizophrenia research, schizophrenia, research funding, research, remote testing, regulations, recruitment, rare disease, prodromal, pro-cognitive, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, patient engagement, parkinson's disease, pal, paired associates learning, ots, occupational health, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health, mdd, mci, major depression, machine learning, ied, high-frequency testing, high frequency, healthcare, guide, grant, funding, fatigue, ert, epidemiology, emotion recognition, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive load, cognitive impairment, cognitive function, cognitive dysfunction, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, autism, attention, asd, alzheimer's disease, affective cognition, adolescents, absenteeism,